AMETEK, Inc. announced that it has entered into a definitive agreement to acquire Paragon Medical from affiliates of American Securities LLC. The all-cash transaction is valued at approximately $1.9 billion.
Paragon Medical, formerly MW Life Sciences, offers advanced medical manufacturing and design for medical devices, components and products. It is based in Pierceton, Indiana. Paragon Medical serves a wide range of specialty applications including orthopedics, minimally invasive surgery, robotic surgery and drug delivery. Paragon’s product portfolio includes single-use and consumable surgical instruments and implantable components sold to a diverse blue-chip customer base of medical device manufacturers. According to the original deal press release, Paragon Medical has annual sales of approximately $500 million.
AMETEK, Inc. is a global provider of industrial technology solutions serving a diverse set of niche markets with annual sales more than $6 billion.
According to data captured in the LevinPro HC database, this transaction marks the 91st Medical Devices acquisition of 2023, as well as the largest Medical Devices transaction by purchase price for the year.
